| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new PET/CT volumetric prognostic index for non-small cell lung cancer
|
Zhang, Hao
|
|
2015
|
89 |
1 |
p. 43-49
7 p.
|
artikel
|
| 2 |
A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies
|
Gubens, Matthew A.
|
|
2015
|
89 |
1 |
p. 57-60
4 p.
|
artikel
|
| 3 |
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG–ACRIN Cancer Research Group (E2511)
|
Owonikoko, Taofeek K.
|
|
2015
|
89 |
1 |
p. 66-70
5 p.
|
artikel
|
| 4 |
A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor
|
Wilson, David O.
|
|
2015
|
89 |
1 |
p. 31-37
7 p.
|
artikel
|
| 5 |
Characteristics of clinical N0 metastatic non-small cell lung cancer
|
Tamura, Tomohiro
|
|
2015
|
89 |
1 |
p. 71-75
5 p.
|
artikel
|
| 6 |
Contents
|
|
|
2015
|
89 |
1 |
p. v-vi
nvt p.
|
artikel
|
| 7 |
Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
|
Nakamura, Shota
|
|
2015
|
89 |
1 |
p. 38-42
5 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2015
|
89 |
1 |
p. iii-
1 p.
|
artikel
|
| 9 |
Immunohistochemical characterization of the mTOR pathway in stage-I non-small-cell lung carcinoma
|
Shin, Eun
|
|
2015
|
89 |
1 |
p. 13-18
6 p.
|
artikel
|
| 10 |
Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?
|
Vincenten, Julien P.L.
|
|
2015
|
89 |
1 |
p. 19-26
8 p.
|
artikel
|
| 11 |
Mixed mucoepidermoid carcinoma and adenocarcinoma of the lung: Two cases with unusual histologic features
|
Hsieh, Min-Shu
|
|
2015
|
89 |
1 |
p. 80-83
4 p.
|
artikel
|
| 12 |
Platinum derivatives alone, a reasonable option to treat locally advanced non-small cell lung cancer with chemo-radiotherapy
|
Sanz Rubiales, Álvaro
|
|
2015
|
89 |
1 |
p. 84-85
2 p.
|
artikel
|
| 13 |
Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung
|
Lee, Mi-Sun
|
|
2015
|
89 |
1 |
p. 8-12
5 p.
|
artikel
|
| 14 |
Prediction of risk of lung cancer in populations and in pulmonary nodules: Significant progress to drive changes in paradigms
|
Baldwin, David R.
|
|
2015
|
89 |
1 |
p. 1-3
3 p.
|
artikel
|
| 15 |
Prophylactic cranial irradiation (PCI). Still a no-brainer?
|
Davey, Phillip
|
|
2015
|
89 |
1 |
p. 4-7
4 p.
|
artikel
|
| 16 |
Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702
|
Inoue, Akira
|
|
2015
|
89 |
1 |
p. 61-65
5 p.
|
artikel
|
| 17 |
Risk of malignancy in pulmonary nodules: A validation study of four prediction models
|
Al-Ameri, Ali
|
|
2015
|
89 |
1 |
p. 27-30
4 p.
|
artikel
|
| 18 |
Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
|
Chaudhuri, Aadel A.
|
|
2015
|
89 |
1 |
p. 50-56
7 p.
|
artikel
|
| 19 |
Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases
|
Subbiah, Vivek
|
|
2015
|
89 |
1 |
p. 76-79
4 p.
|
artikel
|
Tijdschrift beschrijving